Frequently prescribed medications for gastric acidity, such as proton pump inhibitors, are the subject of recurring discussions about their long-term safety. Previous studies had indeed cast doubt regarding a possible increased risk of stomach cancer, fueling uncertainty among patients and clinicians.
A vast investigation conducted in five Nordic countries now provides some clarity. By analyzing medical information covering more than a quarter of a century, scientists were able to examine this hypothesis with exceptional precision.
Illustration image Pixabay
To do this, the team compared, using national health registries, several thousand cases of gastric cancer to a large control group. Particular attention was paid to excluding factors that could distort the results, such as early symptoms of the disease or medication intake in the year before diagnosis. This method thus helped limit external influences.
After accounting for various elements like
Helicobacter pylori infection or lifestyle, the researchers found no association between the prolonged use of proton pump inhibitors and the onset of cancer. This observation also applies to other antacid treatments. These data, published in
The BMJ, cover the period from 1994 to 2020.
This research, although observational in nature and unable to establish a direct causal link, benefits from a robust methodology that limits the errors of past studies. Its authors believe these results are likely to reassure people in need of long-term treatment. They specify that the investigation incorporated many known risk factors.
For healthcare professionals, this work offers a reliable foundation for guiding prescriptions. It helps alleviate apprehensions and optimize the management of common digestive disorders. The scale of the analysis, with participants from different countries, reinforces the robustness of the observations.
The role of gastric acid in health
Gastric acid is essential for digestion, as it participates in breaking down food and defending against certain bacteria. Produced by specialized cells in the stomach, it maintains an environment conducive to nutrient absorption. In its absence, the digestive process would be less efficient.
When this acid is reduced by medications like proton pump inhibitors, it can alleviate symptoms such as heartburn or ulcers. However, this reduction had raised questions, notably the fear that it might encourage the proliferation of harmful bacteria, potentially linked to a tumor risk.
Previous investigations had explored this lead, but sometimes with less rigorous approaches. The recent work demonstrates that with appropriate adjustment of parameters, no significant link emerges. This indicates that a medically justified reduction in acidity is not accompanied by an additional risk of stomach cancer.